And what's interesting is if you look at the price elasticity, if you look at the correlation between these two, as the anti-retrovirals come down, the number of people you can treat goes radically up. And the Clinton Foundation and WHO believe that they can treat three million people worldwide by 2005 -- two million in sub-Saharan Africa.